Legend Biotech CorpNASDAQ:LEGN
- LAST PRICE47.4100
- TODAY'S CHANGE (%)1.1100 (2.3974%)
- Bid / Lots46.6800/ 2
- Ask / Lots47.5900/ 1
- Open / Previous Close46.3700 / 46.3000
- Day Range
- 52 Week Range
- Volume447,899
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | LEGN |
|---|---|---|
| 09:32 ET | 4294 | 46.3266 |
| 09:34 ET | 510 | 46.385 |
| 09:36 ET | 1662 | 46.46 |
| 09:38 ET | 1298 | 46.88 |
| 09:41 ET | 300 | 46.92 |
| 09:43 ET | 500 | 46.64 |
| 09:45 ET | 400 | 46.51 |
| 09:48 ET | 400 | 46.61 |
| 09:50 ET | 200 | 46.69 |
| 09:52 ET | 596 | 46.55 |
| 09:54 ET | 600 | 46.6 |
| 09:56 ET | 345 | 46.54 |
| 09:57 ET | 100 | 46.525 |
| 09:59 ET | 1687 | 46.75 |
| 10:01 ET | 1680 | 46.775 |
| 10:03 ET | 300 | 46.85 |
| 10:06 ET | 800 | 46.93 |
| 10:08 ET | 7407 | 47.19 |
| 10:10 ET | 3012 | 47.23 |
| 10:12 ET | 350 | 47.29 |
| 10:14 ET | 300 | 47.28 |
| 10:15 ET | 915 | 47.35 |
| 10:17 ET | 1377 | 47.3 |
| 10:19 ET | 1300 | 47.47 |
| 10:21 ET | 3420 | 47.5 |
| 10:24 ET | 700 | 47.49 |
| 10:26 ET | 822 | 47.525 |
| 10:28 ET | 6614 | 47.595 |
| 10:30 ET | 3848 | 47.58 |
| 10:32 ET | 1749 | 47.45 |
| 10:33 ET | 500 | 47.425 |
| 10:35 ET | 226 | 47.44 |
| 10:37 ET | 400 | 47.395 |
| 10:39 ET | 100 | 47.46 |
| 10:42 ET | 800 | 47.5 |
| 10:44 ET | 400 | 47.55 |
| 10:46 ET | 1640 | 47.55 |
| 10:48 ET | 800 | 47.59 |
| 10:50 ET | 968 | 47.63 |
| 10:51 ET | 636 | 47.68 |
| 10:53 ET | 389 | 47.7 |
| 10:55 ET | 200 | 47.71 |
| 10:57 ET | 200 | 47.73 |
| 11:00 ET | 100 | 47.73 |
| 11:02 ET | 1900 | 47.69 |
| 11:04 ET | 1300 | 47.635 |
| 11:06 ET | 3825 | 47.51 |
| 11:08 ET | 345 | 47.4 |
| 11:09 ET | 200 | 47.48 |
| 11:11 ET | 300 | 47.49 |
| 11:13 ET | 5045 | 47.325 |
| 11:15 ET | 939 | 47.33 |
| 11:18 ET | 1500 | 47.29 |
| 11:20 ET | 300 | 47.3 |
| 11:22 ET | 1268 | 47.1 |
| 11:24 ET | 600 | 46.98 |
| 11:26 ET | 750 | 46.89 |
| 11:27 ET | 1056 | 46.89 |
| 11:31 ET | 1153 | 46.87 |
| 11:33 ET | 8832 | 46.97 |
| 11:36 ET | 903 | 46.93 |
| 11:38 ET | 100 | 46.945 |
| 11:40 ET | 300 | 46.99 |
| 11:44 ET | 200 | 46.94 |
| 11:45 ET | 300 | 46.95 |
| 11:47 ET | 100 | 46.97 |
| 11:49 ET | 200 | 47 |
| 11:51 ET | 599 | 46.97 |
| 11:54 ET | 9200 | 46.9175 |
| 11:56 ET | 2246 | 46.97 |
| 12:00 ET | 1227 | 47.04 |
| 12:02 ET | 400 | 46.995 |
| 12:07 ET | 3520 | 46.92 |
| 12:09 ET | 1799 | 46.83 |
| 12:14 ET | 639 | 46.86 |
| 12:16 ET | 739 | 46.88 |
| 12:18 ET | 705 | 46.9 |
| 12:20 ET | 200 | 46.92 |
| 12:21 ET | 500 | 46.91 |
| 12:23 ET | 2324 | 46.775 |
| 12:25 ET | 100 | 46.78 |
| 12:27 ET | 5768 | 46.65 |
| 12:30 ET | 3034 | 46.8 |
| 12:32 ET | 1458 | 46.87 |
| 12:34 ET | 1691 | 46.93 |
| 12:36 ET | 1110 | 47.1 |
| 12:38 ET | 800 | 47.14 |
| 12:39 ET | 100 | 47.18 |
| 12:41 ET | 700 | 47.13 |
| 12:43 ET | 398 | 47.145 |
| 12:45 ET | 838 | 47.15 |
| 12:48 ET | 673 | 47.2 |
| 12:52 ET | 200 | 47.2 |
| 12:54 ET | 1200 | 47.1 |
| 12:56 ET | 100 | 47.18 |
| 12:59 ET | 800 | 47.1 |
| 01:01 ET | 100 | 47.07 |
| 01:03 ET | 1637 | 47.01 |
| 01:06 ET | 439 | 47.02 |
| 01:08 ET | 342 | 47.04 |
| 01:10 ET | 605 | 47.02 |
| 01:12 ET | 100 | 47 |
| 01:14 ET | 639 | 46.89 |
| 01:15 ET | 743 | 46.95 |
| 01:17 ET | 100 | 46.91 |
| 01:19 ET | 100 | 46.925 |
| 01:21 ET | 754 | 46.98 |
| 01:24 ET | 200 | 46.98 |
| 01:26 ET | 905 | 47.01 |
| 01:28 ET | 318 | 47.025 |
| 01:30 ET | 200 | 47.0331 |
| 01:32 ET | 400 | 47.05 |
| 01:33 ET | 2185 | 47.1 |
| 01:37 ET | 500 | 47.065 |
| 01:42 ET | 500 | 47.05 |
| 01:44 ET | 640 | 47.12 |
| 01:46 ET | 200 | 47.14 |
| 01:48 ET | 100 | 47.14 |
| 01:50 ET | 300 | 47.14 |
| 01:51 ET | 900 | 47.14 |
| 01:53 ET | 903 | 47.15 |
| 01:55 ET | 592 | 47.16 |
| 01:57 ET | 344 | 47.2 |
| 02:00 ET | 400 | 47.185 |
| 02:02 ET | 200 | 47.2 |
| 02:04 ET | 1655 | 47.27 |
| 02:06 ET | 7463 | 47.31 |
| 02:08 ET | 300 | 47.33 |
| 02:09 ET | 950 | 47.38 |
| 02:11 ET | 900 | 47.4 |
| 02:13 ET | 500 | 47.41 |
| 02:18 ET | 200 | 47.41 |
| 02:20 ET | 1100 | 47.385 |
| 02:22 ET | 800 | 47.38 |
| 02:24 ET | 454 | 47.37 |
| 02:26 ET | 2919 | 47.49 |
| 02:27 ET | 2018 | 47.45 |
| 02:29 ET | 300 | 47.48 |
| 02:31 ET | 300 | 47.518 |
| 02:33 ET | 500 | 47.46 |
| 02:36 ET | 400 | 47.475 |
| 02:38 ET | 200 | 47.49 |
| 02:40 ET | 1110 | 47.44 |
| 02:42 ET | 439 | 47.45 |
| 02:44 ET | 3070 | 47.475 |
| 02:45 ET | 1978 | 47.52 |
| 02:47 ET | 1912 | 47.59 |
| 02:49 ET | 5644 | 47.505 |
| 02:51 ET | 700 | 47.5275 |
| 02:54 ET | 5831 | 47.42 |
| 02:56 ET | 700 | 47.39 |
| 02:58 ET | 1020 | 47.31 |
| 03:00 ET | 1500 | 47.345 |
| 03:02 ET | 300 | 47.365 |
| 03:03 ET | 400 | 47.35 |
| 03:05 ET | 895 | 47.35 |
| 03:07 ET | 1228 | 47.34 |
| 03:09 ET | 1100 | 47.3 |
| 03:12 ET | 100 | 47.28 |
| 03:14 ET | 200 | 47.32 |
| 03:16 ET | 100 | 47.27 |
| 03:18 ET | 782 | 47.29 |
| 03:20 ET | 439 | 47.29 |
| 03:21 ET | 2580 | 47.22 |
| 03:23 ET | 500 | 47.22 |
| 03:25 ET | 400 | 47.225 |
| 03:27 ET | 979 | 47.22 |
| 03:30 ET | 474 | 47.23 |
| 03:32 ET | 2779 | 47.25 |
| 03:34 ET | 830 | 47.27 |
| 03:36 ET | 2599 | 47.31 |
| 03:38 ET | 4387 | 47.48 |
| 03:39 ET | 1308 | 47.46 |
| 03:41 ET | 1735 | 47.385 |
| 03:43 ET | 1462 | 47.36 |
| 03:45 ET | 3670 | 47.34 |
| 03:48 ET | 2076 | 47.34 |
| 03:50 ET | 7095 | 47.4 |
| 03:52 ET | 4354 | 47.48 |
| 03:54 ET | 2077 | 47.51 |
| 03:56 ET | 9567 | 47.445 |
| 03:57 ET | 6904 | 47.45 |
| 03:59 ET | 15889 | 47.41 |
Jul 3, 2024
DJ Legend Biotech Is Maintained at Outperform by BMO Capital, from 9:05AM ET on Wednesday Jul 03, 2024 by Dow Jones
9:05AM ET on Wednesday Jul 03, 2024 by Dow JonesDJ Legend Biotech Price Target Maintained With a $73.00/Share by HC Wainwright & Co., from 6:34AM ET on Wednesday Jul 03, 2024 by Dow Jones
6:34AM ET on Wednesday Jul 03, 2024 by Dow Jones
Jul 2, 2024
Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial in Multiple Myeloma, from 8:00AM ET on Tuesday Jul 02, 2024 by Dow Jones
8:00AM ET on Tuesday Jul 02, 2024 by Dow Jones
Jun 21, 2024
DJ Legend Biotech Price Target Maintained With a $86.00/Share by RBC Capital, from 10:34AM ET on Friday Jun 21, 2024 by Dow Jones
10:34AM ET on Friday Jun 21, 2024 by Dow Jones
Jun 17, 2024
DJ Legend Biotech Price Target Maintained With a $90.00/Share by Piper Sandler, from 1:22PM ET on Monday Jun 17, 2024 by Dow Jones
1:22PM ET on Monday Jun 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Legend Biotech Corp | 8.4B | -18.2x | --- |
Ascendis Pharma A/S | 7.9B | -14.2x | --- |
Blueprint Medicines Corp | 7.0B | -24.1x | --- |
Vaxcyte Inc | 8.5B | -18.8x | --- |
Intra-Cellular Therapies Inc | 7.3B | -62.1x | --- |
Cerevel Therapeutics Holdings Inc | 7.5B | -14.9x | --- |
Company Information
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, ciltacabtagene autoleucel (cilta-cel), referred to as LCAR- B38M, is an autologous chimeric antigen receptor (CAR-T) cell therapy that targets the B-cell maturation antigen (BCMA), which is a highly expressed protein in several hematologic malignancies, including multiple myeloma (MM). In addition to cilta-cel, the Company has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It is also engaged in developing an allogeneic gamma delta CAR-T product candidate and an allogeneic CAR-NK product candidate targeting BCMA for MM.
Contact Information
- Headquarters
- 2101 Cottontail LaneSOMERSET, NJ, United States 08873
- Phone
- 732-317-5050
- Fax
- ---
Executives
- Chairman of the Board
- Fangliang Zhang
- Chief Executive Officer, Director
- Ying Huang
- Chief Financial Officer
- Lori Macomber
- Director
- Ye Wang
- Director
- Li Zhu
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $8.4B |
|---|---|
Revenue (TTM) | $342.8M |
Shares Outstanding | 182.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.11 |
EPS | $-2.60 |
Book Value | $6.88 |
P/E Ratio | -18.2x |
Price/Sales (TTM) | 24.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -157.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
